Skip to content

Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery

Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02385344
Acronym
REQUEST
Enrollment
1046
Registered
2015-03-11
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2018-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Bypass

Brief summary

The purpose of the registry is to collect information regarding the number and type of coronary artery bypass (CAB) surgical procedure changes that are made based on intraoperative guidance information using transit time flow measurements (TTFM) and ultrasound image capabilities provided with the Medistim device.

Interventions

DEVICEMedistim device

This registry is intended to document surgical findings, procedural changes, and adverse events occurring prior to discharge

Sponsors

Medistim ASA
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Subject has been scheduled for coronary bypass surgery * Subject understands the nature of the procedure and has signed the subject informed consent prior to the procedure * Subject has been diagnosed with 2-3 vessel disease

Exclusion criteria

* Subject is scheduled for other surgical procedures during the bypass surgery (valve replacement/repair, carotid endarterectomy, etc.) * Subject is known to be suffering from any psychological, developmental, physical, or emotional disorder that the investigator feels would interfere with surgery or follow-up testing * Subject is undergoing an emergency cardiac bypass surgery * Subject has history or presence of muscle disease (i.e. myopathy, myalgia, myasthenia, rhabdomyolysis) with or without concomitant CK-elevation \> 5 ULN that cannot be ascribed to any other medical condition (e.g. myocardial infarction) * Subject has any condition that the investigator believes should exclude him/her from this registry

Design outcomes

Primary

MeasureTime frameDescription
Change in planned surgical procedureDay 1 (During Surgery)Identify how often epiaortic scanning With the Medistim Device, leads to a change in the planned surgical procedure and to identify the reason and the procedure change
Procedure adaptionsDay 1 (During surgery)Identify the procedure adaptions made by a surgeon when TTFM and/or Medistim ultrasound imaging identify suboptimal graft function

Secondary

MeasureTime frameDescription
Record number of revisionsDay 1 (During surgery)Record how many Cardiac bypass patients experience intraoperative graft revision, the type of revision, and the key identifier motivating the revision
Record number of eventsDay 1-14 (During hospitalization)Record post-surgical major adverse cardiac and cerebral events (MACCE) of all bypass procedure patients entered into the registry and occuring prior to discharge
Incidence rate2 years (Throughout the study)To determine the incidence rate of Serious Adverse Events (SAE) and/or Unanticipated Adverse Events (UAE) throughout the registry

Countries

Canada, Germany, Italy, Netherlands, United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026